Annovis Bio is down -16.8%, or -$1.56 to $7.72.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANVS:
- Annovis Bio falls -8.5%
- Annovis Bio Shares Surge on Positive Parkinson’s Study Data
- Annovis Bio’s buntanetap shows efficacy in Phase 3 Parkinson’s study
- Annovis Bio files provisional patent for manufacturing process of buntanetap
- Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap